Fig. 2From: Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSPQuantification of (a) annexin A1 (AnxA1) plasma levels and (b) human T-lymphotropic virus 1 (HTLV-1) proviral load in asymptomatic (AS) patients and patients diagnosed with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). *Median (Mann-Whitney test)Back to article page